ArticleMedicine2025
Hereditary neuropathy with liability to pressure palsies with recurrent facial paralysis as main clinical manifestation in a Chinese patient: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleHereditary neuropathy with liability to pressure palsies (HNPP) is a rare autosomal dominant genetic disorder characterized by recurrent, brief, and painless nerve paralysis after mild compression. Common peroneal nerve, ulnar nerve, and median nerve are most often involved, but cranial nerve involvement is rare. However, we found a case of HNPP with recurrent facial paralysis as main clinical manifestation. PATIENT CONCERNS: A 31-year-old male experienced 3 episodes of left peripheral facial paralysis over the past 4 years. After hospitalization, we found that the patient had weakened tendon reflex of the limbs and talipes cavus, which highly suggests chronic peripheral neuropathy. DIAGNOSES: The electromyography examination was performed. Motor nerve conduction detection found conduction block of the right common peroneal nerve at the fibular head; sensory nerve conduction detection showed a general slowdown in sensory nerve conduction velocity. The gene sequencing results showed that the patient carries heterozygous deletion of PMP22 gene (exon 1-5 deletion). Therefore, the final diagnosis was HNPP.
interventionsThe patient was treated with oral prednisone and B vitamins. OUTCOMES: The patient was given 20 mg of prednisone once a day for 1 week, and then reduced by 5 mg every 3 days until discontinuation, supplemented with B vitamins. The patient gradually improved and fully recovered to normal after 40 days. LESSONS: Facial nerve paralysis is an atypical clinical presentation of HNPP. This is the first report of HNPP in a Han Chinese population with recurrent facial nerve paralysis as the main symptom. This case has further enriched the clinical spectrum of HNPP, which is worthy of reference for neurologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.